To Get Help Now
Click Here
Today's Date:

WV Man Files Lawsuit against Actos after Developing Bladder Cancer

AddThis Social Bookmark Button

The national law firm of Parker Waichman LLP has filed a lawsuit in U.S. District Court, Western District of Louisiana against Takeda Pharmaceuticals, Inc and Eli Lilly on behalf a plaintiff from West Virginia who was diagnosed with bladder cancer after taking the type two diabetes drug Actos for several years.

According to the lawsuit, the plaintiff began taking Actos in 2005, and because of Actos, he now suffers permanent, severe, and life-threatening personal injury, emotional distress, pain, and lifelong fear of premature death. The complaint alleges that because of his injuries, the plaintiff will have to have treatments, monitoring, and medications for the rest of his life.

The lawsuit says that in 2010, Germany and France suspended sales of Actos after a study found an increased risk of bladder cancer. Days later, the U.S. Food and Drug Administration announced that study data had prompted a safety review of the drug. The study, conducted by Kaiser Permanente found that the risk of bladder cancer increased with the dose and duration of use. In 2011, the FDA released a safety notice stating that taking Actos for longer than a year was associated with 40 percent increase in developing bladder cancer, when compared to people who have never taken the drug.

The lawsuit charges negligence, strict products liability, failure to warn, breach of implied and express warrant, fraud and deceit. The suit seeks punitive and compensatory damages as well as attorney fees and costs, and any additional relief the court deems proper and just. disclaimer: This article: WV Man Files Lawsuit against Actos after Developing Bladder Cancer was posted on Monday, April 30th, 2012 at 7:53 pm at and is filed under Defective Drug Lawsuits.

« »

Comments are closed.